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Ah&act Ligand attachment to polyethylene glycol (PEG) grafted, long circulating liposomes at the polymer terminus is of interest for targeting 
but the effect of positively charged groups is unknown. Amino-polyethylene glycol-phosphatidylethanolamine (AminoPEG-PE), prepared in four 
steps from a-amino-o+hydroxy-PEG, was tested for intluence on liposome interactions in vivo: blood circulation and biodistribution. Despite surface 
amines on each liposome conferring cationic behavior, in vivo properties are comparable to those obtained with methoxy-PEG-PE. The consequences 
are profound for targeting and possibly systemic delivery of cationic lipidic-polynucleotide complexes. 
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1. Introdoction 
Nonspecific interactions and uptake in vivo of liposomes can 
be minimized when methoxypolyethylene glycol (mPEG) is an- 
chored to their surfaces. This is typically achieved by incorpo- 
ration of mPEG- phosphatidylethanolamine (mPEG-PE) con- 
jugate into, so called, sterically stabilized liposomes [l]. The 
reduced biological recognition leads to prolonged circulation 
in blood and selective localization into many different sites of 
pathology: tumors, infections, and intlammations. The use of 
these surface-modified liposomes with therapeutic agents have 
been shown to have considerable advantages over their conven- 
tional counterparts for a number of therapeutic applications, 
not only for release of encapsulated rugs to the blood [2] but 
also for preferential delivery of encapsulated agents into pa- 
thological tissues [3]. 
In addition to mPEG-DSPE, which is the derivative of choice 
for preparation of sterically stabilized liposomes, a few end- 
group functionalized analogs were recently reported (for review 
see [4]). In one study testing the mechanism whereby surface 
modified liposomes avoid recognition and uptake in vivo, ani- 
onic carboxyl groups were positioned at the ends of PEG 
chains. Interestingly, decreased circulation time of carboxyl- 
PEG-containing liposomes was reported, perhaps due to the 
negative charge introduced to the periphery of the graphed 
polymer, and certainly contrary to the expectations of a mech- 
anism relying exclusively on formation of hydrophilic coatings 
[5]. In contrast, hydrazido- PEG-containing liposomes, devel- 
oped for conjugation of antibodies, showed identical behaviour 
to the original sterically stabilized vesicles [6,7]. Hydrazido 
groups (pK, = 3) are neutral at physiological conditions. More 
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recently, some deleterious effects on retention of sterically sta- 
bilized liposomes in the blood by protein ligands, antibodies, 
have been observed [7,8]. Furthermore, positively charged li- 
gands, in particular, may increase interactions with the pre- 
dominantly negatively charged blood components [9, lo]. An 
approach to this problem might be to attach small ligands to 
the lipid surface underneath the polymer. Studies with antibod- 
ies, though, indicate that a loss of binding would be expected 
with such an approach [l 11. 
Surprisingly, little is known of the fate of cationic liposomes 
in vivo as only a few reports exist with ambiguous or conflicting 
results [12]. Generally they have been viewed as incompatible 
in vivo giving accelerated clearance from blood [lo] with sub- 
stantial toxicity, despite an early study indicating only a small 
influence of the cationic surface charge on circulation [13]. 
Recent in vitro studies with plasma revealed the expected tend- 
ency for interactions with negatively charged components lead- 
ing to large aggregates and even hemolysis, although the spe- 
ciflc details are somewhat dependent on the cationic lipid and 
other liposome components [IO]. Despite such a pessimistic 
perspective, in vivo gene expression studies were performed 
using intravenous administration of cationic liposome com- 
plexes with DNA, e.g. see [14], but without examination of the 
in vivo fate of the actual complex. Consequently, the ability to 
utilize cationic ligands or cationic DNA-lipid complexes for in 
vivo applications has been unclear. 
In this report, an amino functional&d PEG conjugate of PE 
was prepared and substituted for mPEG-PE in sterically stabi- 
lized liposomes. The terminal amino group is protonated and 
thus is positively charged at physiological pH, which results in 
an overall neutral, albeit zwitterionic, molecule given the nega- 
tively charged phosphate group of the PE residue. Neverthe- 
less, the relatively large separation between the positive amino 
group and the negative phosphate group by the PEG effectively 
results in a positive surface as determined by direction of migra- 
tion in electrophoresis. Blood circulation kinetics and tissue 
distribution has been determined for these cationic sterically 
stabilized liposomes using an aqueous compartment label, 
67Ga- desferal [15] showing results comparable to mPEG con- 
jugates. These findings indicate that small positively charged 
ligands may be amenable with sterically stabilized liposomes 
when attached to the end of the polymer coating. 
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2. Materials and methods following intravenous administration were nerformed with male and 
female adult Sprague-Dawley rats (22&400 g) following standard pro- 
cedures described elsewhere [20]. Briefly, liposome samples prepared at 
10 mM phospholipid in 10 mM desferoxamine mesylate in isotonic 
saline and radiolabeled with 67Ga-oxine 1151 were administered intrave- 
nously at a dose of about 10-20 mm01 -phospholipid/kg body weight. 
Blood levels at various times were determined by retro-orbital bleeding 
while tissues were obtained surgically after 24 h. Tissue and blood levels 
of 67Ga radioactivity were determined by gamma counter. 
2. I. General 
Partially hydrogenated egg PC (iodine value 40, Asahi Chemical, 
Jauan). Cholesterol (IJSP erade. Croda). DSPE (CalBiochem). DSC 
and B&O (Fluka). Partial conversion ofhydroxylend groups of PEG- 
2000 (Fluka) into primary amines [16] followed by ion-exchange purifi- 
cation according to [17] was employed to prepare a-amino-w-hydroxy- 
PEG. TLC on silica gel G (Analtech) was visualized with iodine vapor, 
Dragendorff- [18] and ninhydrin spray reagents. Liposome particle size 
distribution was determined by dynamic light scattering (Coulter 
N4SD). Phospholipid concentrations were measured by phosphorus 
determination. 
2.2. Preparation of Boc-HN-PEG-OH 
A solution of c+amino-w- hydroxy-PEG (2.0 g, 1 .O mmol) in dioxane 
(8 ml) was treated with Boc,O (0.436 g, 2.0 mmol) overnight. The 
solution was concentrated under reduced pressure and then ethyl ether 
(40 ml) was added. The precipitated product was filtered and dried in 
vacua over P,O,. Yield: 1.89 g (90%). 
TLC (CHCl,-CH,OH 8: 2) & = 0.70, ninhydrin positive after ex- 
posure to HCl vapor. H-NMR (D6 DMSO): d 1.37 (s, ‘Bu, 9H), 
3.06 (m, CH,NH, 2H), 3.51 (s, PEG, 180H), 4.52 (t, HO-PEG, 1H). 
2.3. Preparation of Boc-HN-PEG-SC [19] 
Boc-NH-PEG-OH (1.9 e. 0.9 mrnol) was dissolved in acetonitrile 
(2 ml) and treated with DS? (0.46 g, 1.8 mmol) and pyridine (0.36 ml, 
4.55 mmol) overnight. The product was precipitated with ether and then 
recrystallized from isopropanol, filtered and dried over P,Os in vacua. 
Yield: 1.8 g (85%). 
TLC (CHCl,-CH,OH 9:l) & = 0.38. H-NMR (D6 DMSO): d 1.37 
(s, ‘Bu, 9H), 2181 (s, SC, 4I-I);3.05 (m, CH,NH,‘2H), 3.51 (s, PEG, 
= 180H). 4.44 (t. CH,-SC. 2H). 6.7 (br s. NH. 1H) nom. H-NMR 
(CDCl;): d 1.44 (s, Gu, 9H),‘2.83 is, SC-group, 4Hj: 3.30 (br m, 
CH,NH, 2H), 3.64 (s, PEG, =lSOH), 4.46 (t, CH,-SC, 2H), 5.0 (br s, 
NH, 1H) ppm. 
2.4. Preparation of Boc-HN-PEGDSPE 
DSPE (0.33 g, 6.48 mml) was added to a solution of Boc-HN-PEG- 
SC (1.0 a. 0.47 mmol) in chloroform (7 ml). followed bv TEA (0.24 ml. 
1.6 nunil). The resulting suspensionwas vigorously mixed and main: 
mined at 40°C for = 10 min, while the reaction mixture became com- 
pletely clear. The solvent was rotary evaporated and the residue taken 
up in acetonitrile (12 ml). After overnight storage at 4°C the solution 
was centrifuged to separate traces of insoluble unreacted DSPE, evap- 
orated, and the product dried over P,O, in vacua. Yield: 1.1 g (89%). 
TLC (CHCl,-CH,OH 8:2) & = 0.52, ninhydrin positive after exposure 
to HCl vapor. H-NMR (CDCI,): 6 0.88 (t, J = 6.8 Hz, CH?, 6H), 1.26 
(s, CH2, 56H), 1.44 (s, ‘Bu, 9Hkl.58 (br, CH2CH,C = 0,4H), 2.31 (m, 
CH,C = 0. 4H). 3.31 (br m. CHNI-I. 4H). 3.64 (s. PEG. = 18OH). 
4.G.3 (overlaping m, CH,O:P & CH&CONH, 6Hji4.39 (dd, J = 3.2; 
12 Hz, glycerol CH,O- C = 0, 2 H), 5.2 (m, CH, 1H) ppm. Presence 
of TEA was also detected: 6 1.41 (t, J = 7 Hz, CH,, 3H), 3.12 (q, J = 7 
Hz, CH2, 2H) ppm. 
2.5. Preparation of amino-PEGDSPE 
Cleavage of the amino protecting group from BooHN-PEG-DSPE 
was carried out in 4 M HCl in dioxane for 2 h. After removal of the 
solvent and all the volatiles by drying over P,O, in vacua, the product 
was auantitativelv recovered in the form of a white solid. TLC (CHCl,- 
CH@H-H,O 90 :-18 :2) & = 0.29, ninhydrin positive. Disappearance of 
the ‘Bu peak at 1.44 ppm and appearance of two separate peaks at 3.21 
(br m, CH,NH, 2H) and 3.46 (m, CH,NH, 2H) instead of 3.31 (br m, 
CH,NH, 4H), present in the starting material, indicated that the depro- 
tection went to completion. 
2.6. Preparation of liposomes and in vivo studies 
Liposomes composed of amino-PEG-DSPE, partially hydrogenated 
egg PC, and cholesterol in a mole ratio of 0.15 :1.85 :1 with an average 
particle size distribution of 1000 A and 30 to 100 mmol phospholipid/ml 
were prepared by extrusion of multilamellar vesicles (MLV) using de- 
fined pore filters (Nuclepore) according to Woodle et al. [20]. Loading 
of 67Ga-DF as a liposomal radiolabel was achieved as described previ- 
ously [15,20]. In vivo studies of blood circulation and tissue distribution 
3. Results and discussion 
Sterically stabilized liposomes appear to have many applica- 
tions for retention in blood and passive localization of thera- 
peutic agents to sites of pathology. However, their ability to be 
actively targeted with ligands at the end of the polymer coating 
has yet to be fully utilized. Most studies to date have explored 
large proteins, e.g. antibodies [6-81, although small ligands may 
prove more amenable to minimize nonspecific biological inter- 
actions. For these types of ligands, a cationic nature may be 
often encountered. As part of an ongoing effort to prepare 
functionalized PEG-lipids for covalent attachment of potential 
ligands, we synthesized amino- PEG-DSPE. The conjugate was 
prepared as schematically depicted in Fig. 1. Note from the 
conjugate structure that two groups are ionized at near neutral 
pH: the phospho diester of PE residue and the terminal amino 
group. Thus, apart from the presence of long polymeric spacer 
separating the two charged groups the molecule is actually 
similar to PE. 
The synthesis starts with heterobifunctional polymer, a- 
amino-w-hydroxy-PEG. First the amino group was selectively 
protected by Boc-group [16]. The remaining three steps of the 
synthesis were performed as in a previously published method 
for preparation of hydrazido- PEG-DSPE [19]. Briefly, a suc- 
a-amino-cehydroxy-PEG 
I 
I DSC / Pyridine 
6 
DSPE, R = C,,Hs5 
I 
TEA 
I 
6 
4M HCI in Dioxane 
amino-PEG-DSPE 
” 
Fig. 1. Synthesis of amino-PEG-DSPE (n = 45). 
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Table 1 
Tissue distribution in rats 24 hours after I.V. injection 
Sample’ % Injected dose (SD) in selected tissues 
Blood Liver Spleen Kidney Lung Heart L + S/Blood 
mPEG-PE 32.3 (0.4) 8.4 (1.5) 2.7 (2.3) 0.9 (0.3) 0.3 (0.3) 0.7 (0.1) 0.34 
aminoPEG-PE 28.0 (1.8) 7.1 (0.5) 3.1 (0.6) 0.9 (0.2) 0.8 (0.2) 0.5 (0.1) 0.41 
‘Liposome samples as described in section 2 and used in Fig. 2. 
cinimidyl carbonate group, introduced at the hydroxy-end of 
the polymer, was used to form a urethane linkage to the amino 
group of PE and the primary amine functionality of the poly- 
mer regenerated by acidolytic removal of the Boc- group. The 
final product and all the intermediates were characterized by 
both TLC and H-NMR. 
Substitution of amino-PEG-DSPE for the mPEG-PE tradi- 
tionally used for sterically stabilized liposomes did not give rise 
to any noticeable differences in liposome formation nor to 
radiolabel incorporation using the remote loading method 
forming 67Ga-DF [15]. The blood circulation over the first 24 
hours for liposomes containing either amino-PEG-DSPE or 
mPEG-PE at 5 mol% of phospholipid is shown in Fig. 2 and 
selected tissue distribution after 24 hours given in Table 1. 
These results demonstrate comparable blood circulation and 
tissue distribution regardless of the terminal group of the poly- 
mer coating while all other properties of the polymer conjugate 
and liposome composition are the same. 
Liposomes prepared from neutral, yet zwiterionic, amino- 
PEG-DSPE, PC and cholesterol might be expected to carry a 
net neutral charge. Nonetheless, observations of migration di- 
rection in an electrical field were made to determine the effec- 
tive particle surface charge polarity with a microelectrophoresis 
apparatus (Rank Brothers Mark II) using MLV dispersions 
(large particles) in low ionic strength buffer (10 mM NaCl). The 
results obtained were not quantitative but indicated that these 
liposomes move toward the negative electrode and thus the 
amino group must effectively convey a net positive surface 
charge to the liposomes. How this may occur is as follows. Since 
a lipid vesicle of 1000 A contains approximately 80,000 phos- 
pholipid molecules, incorporation of 5 mol percent of amino- 
PEG-PE results in positioning of = 2000 of positively charged 
ammonium ions on the exterior of each vesicle. Their exact 
Q:@2_ 
q zm 
0-O amino-PEG-PE 
0-U methoxy-PEG-PE 
‘. 
0 6 16 
Hours After IV Injection 
24 
Fig. 2. Blood levels in rats of radiolabeled liposomes expressed as a 
percentage of the initial time point reading (l-2 mm). Circles, amino- 
PEG-DSPE containing liposomes; squares, mPEG-DSPE containing 
liposomes. 
location relative to the liposomal surface will depend on the 
conformation and dynamics of the polymer. Previous estimates 
of polymer coating thickness with mPEG- PE of the same 
molecular weight, is on the order of 50 A [21,22]. The same 
thickness is expected for the amino- PEG-PE. Finally, PEG is 
known to shield charges when it is attached to proteins [23] or 
liposomes [21]. This is expected to nullify, at least partially, the 
polar head group charges underneath the polymer. The combi- 
nation of these effects gives rise to the effectively cationic be- 
havior of the amino-PEG-PE liposomes. 
In conclusion, the system described here containing cationic 
PEG periphery of liposomes is well tolerated in vivo without 
loss of prolonged circulation and without noticeable deviations 
in biodistribution as compared to the neutral polymer-contain- 
ing vesicles. It is pertinent to note that cationic liposomes fre- 
quently used to complex with polynucleotides for transfection 
are typically unstable in physiological saline. The cationic li- 
posomes described here do not exhibit such problems. Whether 
this difference depends on surface charge density or on the 
charge being located at the end of a flexible polymer, remains 
to be determined. Regardless, the results have important poten- 
tial implications for utilization of cationic ligands for targeting 
and perhaps, for overall positively charged polynucleotide com- 
plexes. 
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